IFRX
Price
$1.17
Change
+$0.17 (+17.00%)
Updated
Aug 28 closing price
Capitalization
67.75M
62 days until earnings call
LADX
Price
$1.77
Change
-$0.32 (-15.31%)
Updated
Aug 28 closing price
Capitalization
876.31K
Interact to see
Advertisement

IFRX vs LADX

Header iconIFRX vs LADX Comparison
Open Charts IFRX vs LADXBanner chart's image
InflaRx
Price$1.17
Change+$0.17 (+17.00%)
Volume$1.89M
Capitalization67.75M
LadRx
Price$1.77
Change-$0.32 (-15.31%)
Volume$553
Capitalization876.31K
IFRX vs LADX Comparison Chart in %
Loading...
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LADX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IFRX vs. LADX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IFRX is a StrongBuy and LADX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (IFRX: $1.17 vs. LADX: $1.77)
Brand notoriety: IFRX and LADX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IFRX: 549% vs. LADX: 14%
Market capitalization -- IFRX: $67.75M vs. LADX: $876.31K
IFRX [@Biotechnology] is valued at $67.75M. LADX’s [@Biotechnology] market capitalization is $876.31K. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IFRX’s FA Score shows that 0 FA rating(s) are green whileLADX’s FA Score has 0 green FA rating(s).

  • IFRX’s FA Score: 0 green, 5 red.
  • LADX’s FA Score: 0 green, 5 red.
According to our system of comparison, LADX is a better buy in the long-term than IFRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IFRX’s TA Score shows that 5 TA indicator(s) are bullish while LADX’s TA Score has 5 bullish TA indicator(s).

  • IFRX’s TA Score: 5 bullish, 5 bearish.
  • LADX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both IFRX and LADX are a good buy in the short-term.

Price Growth

IFRX (@Biotechnology) experienced а +30.29% price change this week, while LADX (@Biotechnology) price change was +5.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.09%, and the average quarterly price growth was +29.14%.

Reported Earning Dates

IFRX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IFRX($67.7M) has a higher market cap than LADX($876K). LADX YTD gains are higher at: 5.357 vs. IFRX (-52.632). LADX has higher annual earnings (EBITDA): -3.51M vs. IFRX (-44.6M). IFRX has more cash in the bank: 48M vs. LADX (207K). LADX has less debt than IFRX: LADX (0) vs IFRX (599K). IFRX has higher revenues than LADX: IFRX (163K) vs LADX (0).
IFRXLADXIFRX / LADX
Capitalization67.7M876K7,728%
EBITDA-44.6M-3.51M1,272%
Gain YTD-52.6325.357-982%
P/E RatioN/A1.88-
Revenue163K0-
Total Cash48M207K23,188%
Total Debt599K0-
FUNDAMENTALS RATINGS
IFRX vs LADX: Fundamental Ratings
IFRX
LADX
OUTLOOK RATING
1..100
1492
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5737
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LADX's Valuation (43) in the Pharmaceuticals Other industry is in the same range as IFRX (64) in the Biotechnology industry. This means that LADX’s stock grew similarly to IFRX’s over the last 12 months.

LADX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as IFRX (100) in the Biotechnology industry. This means that LADX’s stock grew similarly to IFRX’s over the last 12 months.

LADX's SMR Rating (100) in the Pharmaceuticals Other industry is in the same range as IFRX (100) in the Biotechnology industry. This means that LADX’s stock grew similarly to IFRX’s over the last 12 months.

LADX's Price Growth Rating (37) in the Pharmaceuticals Other industry is in the same range as IFRX (57) in the Biotechnology industry. This means that LADX’s stock grew similarly to IFRX’s over the last 12 months.

LADX's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as IFRX (100) in the Biotechnology industry. This means that LADX’s stock grew similarly to IFRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IFRXLADX
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 19 days ago
86%
Bearish Trend 25 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LADX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ECCC23.310.03
+0.14%
Eagle Point Credit Company
IPG26.69-0.23
-0.85%
Interpublic Group of Companies (The)
LION6.37-0.08
-1.24%
Lionsgate Studios Corp
XOMA32.70-0.98
-2.91%
XOMA Royalty Corporation
BDSX0.45-0.02
-5.02%
Biodesix

IFRX and

Correlation & Price change

A.I.dvisor tells us that IFRX and NNVC have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and NNVC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
+17.00%
NNVC - IFRX
30%
Poorly correlated
-0.35%
VERA - IFRX
28%
Poorly correlated
+1.23%
ALLO - IFRX
28%
Poorly correlated
+1.72%
TENX - IFRX
26%
Poorly correlated
+0.17%
ARWR - IFRX
26%
Poorly correlated
+2.52%
More

LADX and

Correlation & Price change

A.I.dvisor tells us that LADX and TCRX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LADX and TCRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LADX
1D Price
Change %
LADX100%
-15.31%
TCRX - LADX
22%
Poorly correlated
-2.67%
MREO - LADX
22%
Poorly correlated
-0.57%
NXTC - LADX
21%
Poorly correlated
-2.01%
NICXF - LADX
20%
Poorly correlated
N/A
IFRX - LADX
20%
Poorly correlated
+17.00%
More